P F
1 Abr, 2022

Policies recently reviewed for annual update

The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com:

  • Bioimpedance Devices for Detection and Management of Lymphedema
  • Bone Turnover Markers for the Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover
  • Breast Pump - Hospital Grade
  • Drug Testing
  • Electrical Stimulation and Electromagnetic Therapy for Wound Treatment
  • Glucose Monitoring - Continuous
  • Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease
  • Human Leukocyte Antigen (HLA) Testing Mandate
  • Hyperbaric Oxygen Therapy
  • Immune Cell Function Assay
  • Intracellular Micronutrient Analysis
  • Laser Treatment of Onychomycosis
  • Measurement of Serum Antibodies to Selected Biologic Agents
  • Measurement of Small Low-Density Lipoprotein (LDL) Particles
  • Medical Necessity
  • Multimarker Serum Testing Related to Ovarian Cancer
  • New Technology and Miscellaneous Services
  • Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease
  • Pulsed Radiofrequency for the Treatment of Chronic Pain
  • Radiofrequency Coblation Tenotomy for Musculoskeletal Conditions
  • Serum Biomarker Human Epididymis Protein 4
  • Transcutaneous Electrical Nerve Stimulation
  • Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance
  • Vitamin-D Testing

We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the drop-down “Draft Medical Policies."